Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Genetics
Volume 2017, Article ID 6390545, 8 pages
https://doi.org/10.1155/2017/6390545
Case Report

FOXE1 Mutation Screening in a Case with Cleft Lip, Hypothyroidism, and Thyroid Carcinoma: A New Syndrome?

1Ciprés Grupo Médico S.C. (CGM), Felipe Villanueva 700, Col. Morelos, 50120 Toluca, MEX, Mexico
2Universidad Autónoma del Estado de México (UAEMex), Felipe Villanueva Sur 1209, Col. Rancho Dolores, 50170 Toluca, MEX, Mexico
3Programa de Maestría en Ciencias Bioquímicas, Universidad Nacional Autónoma de México (UNAM), Mexico City, Mexico
4Instituto Nacional de Medicina Genómica (INMEGEN), Mexico City, Mexico

Correspondence should be addressed to Hugo Mendieta-Zerón; moc.oohay@47_hzem

Received 3 May 2017; Revised 19 July 2017; Accepted 30 July 2017; Published 27 August 2017

Academic Editor: Balraj Mittal

Copyright © 2017 Hugo Mendieta-Zerón et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. P. Fernández, A. López-Márquez, Á. M. Martínez, G. Gómez-López, and P. Santisteban, “New Insights into FoxE1 Functions: Identification of Direct FoxE1 Targets in Thyroid Cells,” PLoS ONE, vol. 8, no. 5, Article ID e62849, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. M. L. Marazita, J. C. Murray, A. C. Lidral et al., “Meta-analysis of 13 genome scans reveals multiple cleft lip/palate genes with novel loci on 9q21 and 2q32-35,” American Journal of Human Genetics, vol. 75, no. 2, pp. 161–173, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. L. M. Moreno, M. A. Mansilla, S. A. Bullard et al., “FOXE1 association with both isolated cleft lip with or without cleft palate, and isolated cleft palate,” Human Molecular Genetics, vol. 18, no. 24, pp. 4879–4896, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. A. do Rego Borges, J. Sá, R. Hoshi et al., “Genetic risk factors for nonsyndromic cleft lip with or without cleft palate in a Brazilian population with high African ancestry,” American Journal of Medical Genetics, Part A, vol. 167, no. 10, pp. 2344–2349, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. A. C. Lidral, H. Liu, S. A. Bullard et al., “A single nucleotide polymorphism associated with isolated cleft lip and palate, thyroid cancer and hypothyroidism alters the activity of an oral epithelium and thyroid enhancer near FOXE1,” Human Molecular Genetics, vol. 24, no. 14, Article ID ddv047, pp. 3895–3907, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. I. Landa, S. Ruiz-Llorente, C. Montero-Conde et al., “The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors,” PLoS Genetics, vol. 5, no. 9, Article ID e1000637, p. e1000637, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. K. U. Ludwig, A. C. Böhmer, M. Rubini et al., “Strong association of variants around FOXE1 and orofacial clefting,” Journal of Dental Research, vol. 93, no. 4, pp. 376–381, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. K. U. Ludwig, A. C. Böhmer, J. Bowes et al., “Imputation of orofacial clefting data identifies novel risk loci and sheds light on the genetic background of cleft lip ± cleft palate and cleft palate only,” Human Molecular Genetics, vol. 26, no. 4, pp. 829–842, 2017. View at Publisher · View at Google Scholar
  9. R. A. Tomaz, I. Sousa, J. G. Silva et al., “FOXE1 polymorphisms are associated with familial and sporadic nonmedullary thyroid cancer susceptibility,” Clinical Endocrinology, vol. 77, no. 6, pp. 926–933, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Somuncu, A. Karatas, S. Ferahman et al., “The investigation of foxe1 variations in papillary thyroid carcinoma,” International Journal of Clinical and Experimental Pathology, vol. 8, no. 10, pp. 13458–13464, 2015. View at Google Scholar · View at Scopus
  11. M. Bullock, E. L. Duncan, C. O'Neill et al., “Association of FOXE1 polyalanine repeat region with papillary thyroid cancer,” Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 9, pp. E1814–E1819, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Bychkov, V. Saenko, M. Nakashima et al., “Patterns of FOXE1 expression in papillary thyroid carcinoma by immunohistochemistry,” Thyroid, vol. 23, no. 7, pp. 817–828, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Chrisoulidou, M. Boudina, A. Tzemailas et al., “Histological subtype is the most important determinant of survival in metastatic papillary thyroid cancer,” Thyroid Research, vol. 4, no. 1, article no. 12, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Maillard, F. Damiola, E. Clero et al., “Common variants at 9q22.33, 14q13.3, and ATM loci, and risk of differentiated thyroid cancer in the French Polynesian population,” PLoS ONE, vol. 10, no. 4, Article ID e0123700, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Penna-Martinez, F. Epp, H. Kahles et al., “FOXE1 association with differentiated thyroid cancer and its progression,” Thyroid, vol. 24, no. 5, pp. 845–851, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. A. P. Estrada-Florez, M. E. Bohórquez, R. Sahasrabudhe et al., “Clinical features of Hispanic thyroid cancer cases and the role of known genetic variants on disease risk,” Medicine (United States), vol. 95, no. 32, Article ID e4148, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. J. S. Pereira, J. G. da Silva, R. A. Tomaz et al., “Identification of a novel germline FOXE1 variant in patients with familial non-medullary thyroid carcinoma (FNMTC),” Endocrine, vol. 49, no. 1, pp. 204–214, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. J. C. Denny, D. C. Crawford, M. D. Ritchie et al., “Variants near FOXE1 are associated with hypothyroidism and other thyroid conditions: Using electronic medical records for genome- and phenome-wide studies,” American Journal of Human Genetics, vol. 89, no. 4, pp. 529–542, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Lesage, V. Drouet, E. Majounie et al., “Loss of VPS13C function in autosomal-recessive parkinsonism causes mitochondrial dysfunction and increases pink1/parkin-dependent mitophagy,” The American Journal of Human Genetics, vol. 98, no. 3, pp. 500–513, 2016. View at Publisher · View at Google Scholar
  20. N. Eriksson, J. Y. Tung, A. K. Kiefer et al., “Novel associations for hypothyroidism include known autoimmune risk loci,” PLoS ONE, vol. 7, no. 4, Article ID e34442, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. I. Bariş, A. E. Arisoy, A. Smith et al., “A novel missense mutation in human TTF-2 (FKHL15) gene associated with congenital hypothyroidism but not athyreosis,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 10, pp. 4183–4187, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Carré, R. T. Hamza, D. Kariyawasam et al., “A novel FOXE1 mutation (R73S) in bamforth-lazarus syndrome causing increased thyroidal gene expression,” Thyroid, vol. 24, no. 4, pp. 649–654, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Carré, M. Castanet, S. Sura-Trueba et al., “Polymorphic length of FOXE1 alanine stretch: Evidence for genetic susceptibility to thyroid dysgenesis,” Human Genetics, vol. 122, no. 5, pp. 467–476, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. C. M. Pereda, F. Lesueur, M. Pertesi et al., “Common variants at the 9q22.33, 14q13.3 and ATM loci, and risk of differentiated thyroid cancer in the Cuban population,” BMC Genetics, vol. 16, no. 1, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. E. Bonora, C. Rizzato, C. Diquigiovanni et al., “The FOXE1 locus is a major genetic determinant for familial nonmedullary thyroid carcinoma,” International Journal of Cancer, vol. 134, no. 9, pp. 2098–2107, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Katoh and M. Katoh, “Transcriptional mechanisms of WNT5A based on NF-κB, Hedgehog, TGFβ, and Notch signaling cascades,” International Journal of Molecular Medicine, vol. 23, no. 6, pp. 763–769, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. A. E. Walts, J. M. Mirocha, and S. Bose, “Follicular variant of papillary thyroid carcinoma (FVPTC): histological features, BRAF V600E mutation, and lymph node status,” Journal of Cancer Research and Clinical Oncology, 2015. View at Publisher · View at Google Scholar
  28. M. Castanet, S.-M. Park, A. Smith et al., “A novel loss-of-function mutation in TTF-2 is associated with congenital hypothyroidism, thyroid agenesis and cleft palate,” Human Molecular Genetics, vol. 11, no. 17, pp. 2051–2059, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. M. De Felice, C. Ovitt, E. Biffali et al., “A mouse model for hereditary thyroid dysgenesis and cleft palate,” Nature Genetics, vol. 19, no. 4, pp. 395–398, 1998. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Frebourg, C. Oliveira, P. Hochain et al., “Cleft lip/palate and CDH1/E-cadherin mutations in families with hereditary diffuse gastric cancer,” Journal of Medical Genetics, vol. 43, no. 2, pp. 138–142, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. P. R. Benusiglio, O. Caron, E. Consolino et al., “Cleft lip, cleft palate, hereditary diffuse gastric cancer and germline mutations in CDH1,” International Journal of Cancer, vol. 132, no. 10, p. 2470, 2013. View at Publisher · View at Google Scholar · View at Scopus